204 related articles for article (PubMed ID: 30611565)
21. Surgical therapy of neuroendocrine neoplasm with hepatic metastasis: patient selection and prognosis.
Watzka FM; Fottner C; Miederer M; Schad A; Weber MM; Otto G; Lang H; Musholt TJ
Langenbecks Arch Surg; 2015 Apr; 400(3):349-58. PubMed ID: 25682055
[TBL] [Abstract][Full Text] [Related]
22. Outcome after resection and radiofrequency ablation of liver metastases from small intestinal neuroendocrine tumours.
Norlén O; Stålberg P; Zedenius J; Hellman P
Br J Surg; 2013 Oct; 100(11):1505-14. PubMed ID: 24037573
[TBL] [Abstract][Full Text] [Related]
23. Quality of life after treatment of neuroendocrine liver metastasis.
Spolverato G; Bagante F; Wagner D; Buettner S; Gupta R; Kim Y; Maqsood H; Pawlik TM
J Surg Res; 2015 Sep; 198(1):155-64. PubMed ID: 26095419
[TBL] [Abstract][Full Text] [Related]
24. Hepatic metastases of gastroenteropancreatic neuroendocrine tumors: safe hepatic surgery.
Jaeck D; Oussoultzoglou E; Bachellier P; Lemarque P; Weber JC; Nakano H; Wolf P
World J Surg; 2001 Jun; 25(6):689-92. PubMed ID: 11376398
[TBL] [Abstract][Full Text] [Related]
25. Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis.
Mayo SC; de Jong MC; Pulitano C; Clary BM; Reddy SK; Gamblin TC; Celinksi SA; Kooby DA; Staley CA; Stokes JB; Chu CK; Ferrero A; Schulick RD; Choti MA; Mentha G; Strub J; Bauer TW; Adams RB; Aldrighetti L; Capussotti L; Pawlik TM
Ann Surg Oncol; 2010 Dec; 17(12):3129-36. PubMed ID: 20585879
[TBL] [Abstract][Full Text] [Related]
26. Surgical resection improves the outcome of the patients with neuroendocrine tumor liver metastases: large data from Asia.
Du S; Wang Z; Sang X; Lu X; Zheng Y; Xu H; Xu Y; Chi T; Zhao H; Wang W; Cui Q; Zhong S; Huang J; Mao Y
Medicine (Baltimore); 2015 Jan; 94(2):e388. PubMed ID: 25590842
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of laparoscopic tumor ablation for neuroendocrine liver metastases: a 20-year experience.
Kose E; Kahramangil B; Aydin H; Donmez M; Takahashi H; Aucejo F; Siperstein A; Berber E
Surg Endosc; 2020 Jan; 34(1):249-256. PubMed ID: 30945061
[TBL] [Abstract][Full Text] [Related]
28. Palliative resection of the primary tumor in 442 metastasized neuroendocrine tumors of the pancreas: a population-based, propensity score-matched survival analysis.
Hüttner FJ; Schneider L; Tarantino I; Warschkow R; Schmied BM; Hackert T; Diener MK; Büchler MW; Ulrich A
Langenbecks Arch Surg; 2015 Aug; 400(6):715-23. PubMed ID: 26198970
[TBL] [Abstract][Full Text] [Related]
29. Resection of the primary pancreatic neuroendocrine tumor in patients with unresectable liver metastases: possible indications for a multimodal approach.
Bertani E; Fazio N; Botteri E; Chiappa A; Falconi M; Grana C; Bodei L; Papis D; Spada F; Bazolli B; Andreoni B
Surgery; 2014 Apr; 155(4):607-14. PubMed ID: 24582492
[TBL] [Abstract][Full Text] [Related]
30. Resection of liver metastasis from neuroendocrine tumors: evaluation of results and prognostic factors.
Valadares LJ; Costa Junior W; Ribeiro HS; Diniz AL; Coimbra FJ; Herman P
Rev Col Bras Cir; 2015; 42(1):25-31. PubMed ID: 25992697
[TBL] [Abstract][Full Text] [Related]
31. Primary tumour resection may improve survival in functional well-differentiated neuroendocrine tumours metastatic to the liver.
Citterio D; Pusceddu S; Facciorusso A; Coppa J; Milione M; Buzzoni R; Bongini M; deBraud F; Mazzaferro V
Eur J Surg Oncol; 2017 Feb; 43(2):380-387. PubMed ID: 27956320
[TBL] [Abstract][Full Text] [Related]
32. Small intestinal neuroendocrine tumors with liver metastases and resection of the primary: Prognostic factors for decision making.
Bertani E; Falconi M; Grana C; Botteri E; Chiappa A; Misitano P; Spada F; Ravizza D; Bazolli B; Fazio N
Int J Surg; 2015 Aug; 20():58-64. PubMed ID: 26074290
[TBL] [Abstract][Full Text] [Related]
33. Isolated liver metastases from neuroendocrine tumors: does resection prolong survival?
Chen H; Hardacre JM; Uzar A; Cameron JL; Choti MA
J Am Coll Surg; 1998 Jul; 187(1):88-92; discussion 92-3. PubMed ID: 9660030
[TBL] [Abstract][Full Text] [Related]
34. Management and outcomes of patients with recurrent neuroendocrine liver metastasis after curative surgery: An international multi-institutional analysis.
Spolverato G; Bagante F; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Weiss M; Pawlik TM
J Surg Oncol; 2017 Sep; 116(3):298-306. PubMed ID: 28513896
[TBL] [Abstract][Full Text] [Related]
35. [Liver resection for non-colorectal, non-neuroendocrine liver metastases--is hepatic resection justified as part of the oncosurgical treatment?].
Lehner F; Ramackers W; Bektas H; Becker T; Klempnauer J
Zentralbl Chir; 2009 Sep; 134(5):430-6. PubMed ID: 19757343
[TBL] [Abstract][Full Text] [Related]
36. Treatment of Neuroendocrine Liver Metastases.
Farley HA; Pommier RF
Surg Oncol Clin N Am; 2016 Jan; 25(1):217-25. PubMed ID: 26610783
[TBL] [Abstract][Full Text] [Related]
37. Combined resection and RFA in colorectal liver metastases: stratification of long-term outcomes.
Sasaki K; Margonis GA; Andreatos N; Kim Y; Wilson A; Gani F; Amini N; Pawlik TM
J Surg Res; 2016 Nov; 206(1):182-189. PubMed ID: 27916360
[TBL] [Abstract][Full Text] [Related]
38. Palliative surgery in patients with unresectable colorectal liver metastases: a propensity score matching analysis.
Yoon YS; Kim CW; Lim SB; Yu CS; Kim SY; Kim TW; Kim MJ; Kim JC
J Surg Oncol; 2014 Mar; 109(3):239-44. PubMed ID: 24165972
[TBL] [Abstract][Full Text] [Related]
39. The surgical management of neuroendocrine tumour hepatic metastases.
Pathak S; Dash I; Taylor MR; Poston GJ
Eur J Surg Oncol; 2013 Mar; 39(3):224-8. PubMed ID: 23290582
[TBL] [Abstract][Full Text] [Related]
40. Risk of Infectious Complications After Simultaneous Gastrointestinal and Liver Resections for Neuroendocrine Tumor Metastases.
Acosta LF; Chacon E; Eman P; Dugan A; Davenport D; Gedaly R
J Surg Res; 2019 Mar; 235():244-249. PubMed ID: 30691802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
